Contact
RESOURCES
Global Point of Care
About Abbott

TOXICOLOGY

iSCREEN™ AND iSCREEN™ Dx URINE TEST DRUG SCREEN DIP CARD

The iScreen™ and iScreen™ Dx Urine Test Drug Screen Dip Card provides multiple drug configurations to meet your needs. It rapidly screens for a broad range of illicit and prescription drugs for a fully customized test program.

iScreen™ Urine Test Drug Screen Flat Cup iScreen™ Urine Test Drug Screen Flat Cup iScreen™ Urine Test Drug Screen Flat Cup
Benefits
  • 1-12 configurations available
  • Available drug test options include: AMP, BAR, BUP, BZO, COC, EDDP, MDMA, MET/mAMP, MOP, MTD, OPI, OXY, PCP, PPX, TCA, THC1
  • Specimen validity combinations include: CR/CRE, GL/GLUT, NI/NIT, OX, pH, S.G.2
  • Simple procedure: collect urine, dip and read results at 5 minutes
  • Administrator remains in control of test dip card
  • Results can be photocopied

References

  1. Drugs of abuse: Amphetamine (AMP1000, AMP500 or AMP300), Barbiturates (BAR300), Benzodiazepines (BZO300), Buprenorphine (BUP10), Cocaine (COC150 or COC300), Methadone Metabolites (EDDP300), Methylenedioxymethamphetamine (MDMA500), Methadone (MTD300), Methamphetamine (MET1000/mAMP1000 or MET500/mAMP500), Opiates (MOP300 or OPI2000), Oxycodone (OXY100), Phencyclidine (PCP25), Propoxyphene (PPX300), Tricyclic Antidepressants (TCA1000) and Marijuana (THC50)
  2. Specimen Validity Tests: Creatinine (CR/CRE), Glutaraldehyde (GL/GLUT), Nitrite (NI/NIT), Oxidants/PCC (OX), pH (pH), Specific Gravity (S.G.)

For in vitro diagnostic use only. CLIA waived options available.

This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result.

Chromatography/Mass Spectrometry (GC/MS) or Liquid Chromatography/Tandem Mass Spectrometry (LC/MS-MS) is the preferred confirmatory method.

Some drug analytes and cutoffs may not be available in all locations, please consult the product insert or your sales representative for more details. Product name and appearance may vary.

©2023 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.

Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy and Cookie Policy. Notice of Privacy Practices: Santa Rosa, CA [pdf 681KB] | Gretna, LA [pdf 135KB] | Richmond, VA [pdf 135KB], HIPAA & Patient Info

Abbott - A Global Leader in Toxicology.

Alere Toxicology is now Abbott Toxicology